Stephens Inc. AR Buys 20,506 Shares of Kenvue Inc. (NYSE:KVUE)

Stephens Inc. AR raised its stake in Kenvue Inc. (NYSE:KVUE) by 12.2% during the 3rd quarter, Holdings Channel.com reports. The firm owned 187,949 shares of the company’s stock after buying an additional 20,506 shares during the quarter. Stephens Inc. AR’s holdings in Kenvue were worth $4,347,000 as of its most recent SEC filing.

A number of other large investors have also added to or reduced their stakes in the company. First Trust Direct Indexing L.P. grew its position in shares of Kenvue by 29.2% in the 1st quarter. First Trust Direct Indexing L.P. now owns 24,463 shares of the company’s stock worth $525,000 after buying an additional 5,524 shares during the last quarter. Diversify Advisory Services LLC acquired a new stake in Kenvue in the first quarter valued at approximately $565,000. Tokio Marine Asset Management Co. Ltd. grew its holdings in Kenvue by 8.3% in the first quarter. Tokio Marine Asset Management Co. Ltd. now owns 41,507 shares of the company’s stock worth $891,000 after purchasing an additional 3,169 shares during the last quarter. Fidelis Capital Partners LLC acquired a new position in shares of Kenvue during the first quarter worth $106,000. Finally, Daiwa Securities Group Inc. lifted its holdings in shares of Kenvue by 18.5% during the 1st quarter. Daiwa Securities Group Inc. now owns 197,654 shares of the company’s stock valued at $4,242,000 after purchasing an additional 30,802 shares during the last quarter. 97.64% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Several brokerages recently issued reports on KVUE. Royal Bank of Canada lowered Kenvue from an “outperform” rating to a “sector perform” rating and set a $24.00 target price on the stock. in a research report on Tuesday, September 24th. Piper Sandler increased their price objective on shares of Kenvue from $20.00 to $21.00 and gave the company a “neutral” rating in a research report on Monday, September 23rd. Jefferies Financial Group began coverage on shares of Kenvue in a research report on Tuesday, September 24th. They set a “buy” rating and a $27.00 target price on the stock. Deutsche Bank Aktiengesellschaft raised their price target on shares of Kenvue from $23.00 to $24.00 and gave the stock a “buy” rating in a report on Wednesday, August 7th. Finally, Bank of America boosted their price objective on shares of Kenvue from $24.00 to $27.00 and gave the company a “buy” rating in a report on Tuesday, October 22nd. One research analyst has rated the stock with a sell rating, seven have issued a hold rating and four have given a buy rating to the company. Based on data from MarketBeat, the stock has an average rating of “Hold” and an average target price of $22.64.

Kenvue Stock Performance

Shares of KVUE stock opened at $22.73 on Friday. Kenvue Inc. has a 52-week low of $17.67 and a 52-week high of $23.55. The company has a quick ratio of 0.68, a current ratio of 0.99 and a debt-to-equity ratio of 0.69. The stock has a market cap of $43.53 billion, a PE ratio of 39.19, a price-to-earnings-growth ratio of 3.00 and a beta of 1.35. The business has a 50-day simple moving average of $22.53 and a 200-day simple moving average of $20.41.

Kenvue (NYSE:KVUE) last announced its quarterly earnings results on Tuesday, August 6th. The company reported $0.32 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.28 by $0.04. Kenvue had a return on equity of 21.80% and a net margin of 7.23%. The company had revenue of $4 billion during the quarter, compared to the consensus estimate of $3.93 billion. Kenvue’s revenue for the quarter was down .3% on a year-over-year basis. During the same period in the previous year, the company posted $0.32 earnings per share. On average, equities analysts expect that Kenvue Inc. will post 1.08 EPS for the current year.

Kenvue Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, November 27th. Investors of record on Wednesday, November 13th will be given a dividend of $0.205 per share. The ex-dividend date of this dividend is Wednesday, November 13th. This represents a $0.82 annualized dividend and a yield of 3.61%. Kenvue’s dividend payout ratio is presently 141.38%.

Kenvue Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.